HER2- positive breast cancer / Sara Hurvitz, MD, Division of Hematology/Oncology, david Geffen School of Medicine, University of California, Los Angeles; Kelly Mccann, MD, PHD, Division of Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles.
By: Hurvitz, Sara.
Contributor(s): Hurvitz, Sara [Author.] | Mccann, Kelly [Author.].
Material type:
There are no comments for this item.